Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The financing will be used to accelerate the building of synthetic biology vaccine platforms and advance pipelines of synthetic vaccines to clinical trials.
Lead Product(s): Synthetic vaccine
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: Discovery PlatformProduct Type: Vaccine
Partner/Sponsor/Collaborator: Boehringer Ingelheim GmbH
Deal Size: $14.0 million Upfront Cash: Undisclosed
Deal Type: Financing March 11, 2021